肺癌筛查随访依从性的种族差异:系统综述与荟萃分析
荟萃分析显示黑人人群随访依从性低于白人(OR 0.67,95%CI 0.55-0.80),且在各恶性风险层级均持续存在。
要点
- 黑人人群肺癌筛查随访依从性显著低于白人(OR 0.67)。
- 依从性差异在所有恶性风险层级中均持续存在。
- 中位随访依从率仅37%,整体依从性有待提高。
核心结论
- 黑人患者肺癌筛查随访依从性低于白人,尽管其肺癌死亡获益可能更大。
研究设计与样本
- 初筛18300篇标题和摘要,229篇全文审查,9篇符合纳入标准,7篇进入荟萃分析。
主要发现
- 中位随访依从率为37%(范围16%-82%)。
- 黑人人群随访依从性低于白人(OR 0.67;95%CI 0.55-0.80)。
- 该差异在所有由初始筛查结果确定的恶性风险层级中均持续存在。
- 纳入研究中黑人比例范围为4%-47%,筛查项目结构存在差异。
临床怎么用
- 应加强医生教育并使用筛查项目协调员,重点针对符合条件的黑人患者扩大外展。
局限性
- 专门探讨种族相关肺癌筛查依从障碍的文献仍然有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2013, the United States Preventive Services Taskforce instituted recommendations for annual lung cancer screening (LCS) with low-dose chest CT imaging for high-risk individuals. LCS reduces lung cancer mortality, with greater reduction observed in Black participants in clinical trials. Although racial disparities in lung cancer mortality have been well documented, less is known about disparities in LCS participation and adherence to follow-up in clinical practice. RESEARCH QUESTION: What is the association between race and adherence to LCS follow-up? STUDY DESIGN AND METHODS: A systematic review was conducted through a search of published studies in MEDLINE, PubMed, EMBASE, Web of Science, and Cumulative Index to Nursing and Allied Health Literature Database from database inception through October 2020. We included studies that examined rates of adherence to LCS follow-up and compared rates by race. Studies were pooled using random-effects meta-analysis. RESULTS: We screened 18,300 titles and abstracts, and 229 studies were selected for full-text review. Nine studies met inclusion criteria; seven were included in the meta-analysis. Median adherent follow-up rate was 37% (range, 16%-82%). Notable differences among the studies included the proportion of the Black population (range, 4%-47%) and the structure of the LCS programs. The meta-analyses showed lower adherence to LCS follow-up in the Black population (OR, 0.67; 95% CI, 0.55-0.80). This disparity persisted across all malignancy risk levels determined by initial screening results. INTERPRETATION: Lower adherence to LCS follow-up in Black compared with White patients occurs despite the higher potential lung cancer mortality benefit. Literature specifically addressing race-related barriers to LCS adherence remains limited. To ensure equity in LCS benefits, greater outreach to eligible Black patients should be implemented through increased physician education and use of screening program coordinators to focus on this patient population. TRIAL REGISTRY: PROSPERO; No.: CRD42020214213; URL: http://www.crd.york.ac.uk/PROSPERO.
引用
- Kunitomo Y, Bade B, Gunderson CG, et al. Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis. Chest. 2021. PMID: 34390706. doi:10.1016/j.chest.2021.07.2172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。